ADDIE HOLCOMB: Open Payments
NPI 1942840368 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,593 in 129 payments from 40 companies in 2025. Trend: 2023 $1,386 · 2024 $1,484 · 2025 $2,593
Food & beverage: $2,593
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $226 |
| Janssen Biotech, Inc. | 10 | $187 |
| Merck Sharp & Dohme LLC | 8 | $182 |
| Daiichi Sankyo Inc. | 8 | $159 |
| TerSera Therapeutics LLC | 5 | $159 |
| PFIZER INC. | 7 | $123 |
| Eisai Inc. | 7 | $120 |
| GENZYME CORPORATION | 1 | $106 |
| Incyte Corporation | 5 | $102 |
| Exelixis Inc. | 4 | $74 |
Products named: KEYTRUDA, KISQALI, Zoladex, Lenvima, WAYRILZ, IBRANCE, JAKAFI, DATROWAY.
Industry payments across MS — which companies pay providers there.
